Frödin, J.-E.
39  Ergebnisse:
Personensuche X
?
 
?
4

Quality of life and cost effectiveness in a randomized tria..:

Cashin, P.H. ; Mahteme, H. ; Syk, I....
European Journal of Surgical Oncology.  44 (2018)  7 - p. 983-990 , 2018
 
?
 
?
6

Persistence of Klebsiella pneumoniae ST258 as the predomina..:

Adler, A. ; Hussein, O. ; Ben-David, D....
Journal of Antimicrobial Chemotherapy.  70 (2014)  1 - p. 89-92 , 2014
 
?
 
?
8

270 A phase II study of oral uracil/ftorafu (UFT) plus leuc..:

Glydenkerne, N. ; Glimelius, B. ; Frödin, J.-E....
European Journal of Cancer Supplements.  1 (2003)  5 - p. S83 , 2003
 
?
9

990 Treatment with a combination of mMAb17-1A, GM-CSF, alph..:

Liljefors, M. ; Frödin, J.-E. ; Ragnhammar, P..
European Journal of Cancer Supplements.  1 (2003)  5 - p. S297 , 2003
 
?
10

Treatment with GM-CSF and IL-2 in patients with metastatic ..:

Skog, Hjelm A.-L. ; Wersäll, P. ; Ragnhammar, P...
Cancer Immunology, Immunotherapy.  51 (2002)  5 - p. 255-262 , 2002
 
?
11

Clinical effects of monoclonal antibody 17-1A combined with..:

Hjelm Skog, A.-L. ; Ragnhammar, P. ; Fagerberg, J....
Cancer Immunology, Immunotherapy.  48 (1999)  8 - p. 463-470 , 1999
 
?
13

Induction of an immune network cascade in cancer patients t..:

Fagerberg, J. ; Frödin, J. -E. ; Ragnhammar, P....
Cancer Immunology, Immunotherapy.  38 (1994)  3 - p. 149-159 , 1994
 
?
14

Cytotoxic functions of blood mononuclear cells in patients ..:

Ragnhammar, P. ; Masucci, G. ; Frödin, J -E..
Cancer Immunology Immunotherapy.  35 (1992)  3 - p. 158-164 , 1992
 
1-15